Biotech startups that raised Series B
Updated 23 Oct 2026
1,423
Companies
$48.6B
Last round total
100
Rows shown
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Prolific Machines | Series B | $50.0M | 2026-10-14 | Emeryville | Artificial intelligence |
| 2 | Soufflé Therapeutics | Series B | $135.0M | 2026-10-13 | Boston | Biotech |
| 3 | Sava Technology | Series B | $36.0M | 2026-10-09 | London | Biotech |
| 4 | RadioNano Therapeutics | Series B | $955K | 2026-10-09 | Kyoto | Biotech |
| 5 | Matchpoint Therapeutics | Series B | $150.0M | 2026-10-07 | Cambridge | Biotech |
| 6 | KymaThera | Series B | $80.0M | 2026-10-06 | San Diego | Biotech |
| 7 | Multiply Labs | Series B | $75.0M | 2026-10-06 | San Francisco | Artificial intelligence |
| 8 | WhiteLab Genomics | Series B | $26.0M | 2026-10-05 | Paris | Artificial intelligence |
| 9 | Celaid Therapeutics | Series B | $2.5M | 2026-10-05 | Tokyo | Biotech |
| 10 | AnaCardio | Series B | $70.8M | 2026-09-30 | Solna | Biotech |
| 11 | Astrocyte Pharmaceuticals | Series B | $9.5M | 2026-09-30 | Groton | Biotech |
| 12 | Tiny Health | Series B | $33.0M | 2026-09-29 | Austin | Biotech |
| 13 | NexThera | Series B | $16.2M | 2026-09-28 | Jungang | Biotech |
| 14 | HITS | Series B | $13.5M | 2026-09-28 | Seoul | Artificial intelligence |
| 15 | ALPFA Medical | Series B | $30.0M | 2026-09-25 | Palo Alto | Biotech |
| 16 | Bluesail Surgical | Series B | $104.5M | 2026-09-23 | Shanghai | Biotech |
| 17 | Vapo Health | Series B | $7.5M | 2026-09-23 | Kunshan | Biotech |
| 18 | Aqua Medical | Series B | 2026-09-23 | Pleasanton | Biotech | |
| 19 | Qiantang Longyue | Series B | $14.9M | 2026-09-17 | Hangzhou | Biotech |
| 20 | Maybio Matrix | Series B | 2026-09-17 | Chaoyang | Biotech | |
| 21 | Evvy | Series B | $40.0M | 2026-09-15 | New York | Artificial intelligence |
| 22 | DermaSensor | Series B | $4.0M | 2026-09-09 | Miami | Artificial intelligence |
| 23 | Moonwalk Biosciences | Series B | $70.0M | 2026-09-08 | South San Francisco | Artificial intelligence |
| 24 | MVRIX | Series B | $5.9M | 2026-09-04 | Seoul | Biotech |
| 25 | NeuShen Therapeutics | Series B | $80.0M | 2026-09-03 | Shanghai | Biotech |
| 26 | Superluminal Medicines | Series B | $65.5M | 2026-09-03 | Boston | Artificial intelligence |
| 27 | Medefa | Series B | $14.9M | 2026-09-02 | Zhuhai | Biotech |
| 28 | N-Power Medicine | Series B | $32.0M | 2026-09-01 | Redwood City | Artificial intelligence |
| 29 | NovaGo Therapeutics | Series B | $29.7M | 2026-08-31 | Schlieren | Biotech |
| 30 | Yuce Biotechnology | Series B | $7.4M | 2026-08-31 | Suzhou | Biotech |
| 31 | Pixelgen Technologies | Series B | $15.5M | 2026-08-20 | Stockholm | Biotech |
| 32 | Simnova | Series B | $59.3M | 2026-08-18 | Cambridge | Biotech |
| 33 | Computomics | Series B | $7.3M | 2026-08-18 | Tübingen | Artificial intelligence |
| 34 | Georgiamune | Series B | $92.7M | 2026-08-17 | Gaithersburg | Biotech |
| 35 | Khartis Therapeutics | Series B | $50.0M | 2026-08-13 | San Diego | Biotech |
| 36 | Hongxin Biology | Series B | $14.0M | 2026-08-13 | Shenzhen | Biotech |
| 37 | InduPro | Series B | $77.0M | 2026-08-12 | Seattle | Biotech |
| 38 | Amplifica | Series B | $26.0M | 2026-08-12 | San Diego | Biotech |
| 39 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 40 | Aureka Biotechnologies | Series B | $100.0M | 2026-08-10 | Laguna Hills | Artificial intelligence |
| 41 | Expedition Therapeutics | Series B | $115.0M | 2026-08-05 | San Francisco | Biotech |
| 42 | Mironid | Series B | $45.9M | 2026-08-05 | Glasgow | Biotech |
| 43 | Theradaptive | Series B | $36.2M | 2026-08-04 | Frederick | Biotech |
| 44 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
| 45 | Layerwave Bio | Series B | $13.8M | 2026-07-28 | Daxing | Biotech |
| 46 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 47 | Draig Therapeutics | Series B | $65.0M | 2026-07-14 | Cardiff | Biotech |
| 48 | Illuminare Biotechnologies | Series B | $2.4M | 2026-07-14 | Princeton | Biotech |
| 49 | Huaxia Yuan Group | Series B | 2026-07-14 | Minhang | Biotech | |
| 50 | MindRank AI | Series B | $52.0M | 2026-07-08 | Shanghai | Artificial intelligence |
| 51 | Kuehnle Agrosystems | Series B | $3.0M | 2026-07-06 | Honolulu | Biotech |
| 52 | Pyrotech | Series B | 2026-07-03 | Changping | Biotech | |
| 53 | Inocras | Series B | $20K | 2026-07-01 | San Diego | Artificial intelligence |
| 54 | Neusignal Therapeutics | Series B | $32.8M | 2026-06-30 | Tokyo | Biotech |
| 55 | Etern | Series B | 2026-06-30 | Shanghai | Biotech | |
| 56 | The Protein Brewery | Series B | $20.5M | 2026-06-29 | Breda | Biotech |
| 57 | Oblenio Bio | Series B | $62.0M | 2026-06-25 | Cambridge | Biotech |
| 58 | Ollin Biosciences | Series B | $330.0M | 2026-06-24 | Austin | Biotech |
| 59 | Osanni Bio | Series B | $190.0M | 2026-06-23 | San Francisco | Biotech |
| 60 | Nura Bio | Series B | $73.8M | 2026-06-22 | South San Francisco | Biotech |
| 61 | Cour Pharmaceuticals Development | Series B | $50.0M | 2026-06-18 | Skokie | Biotech |
| 62 | Vertoro | Series B | $11.5M | 2026-06-17 | Geleen | Biotech |
| 63 | FNCT Biotech | Series B | $14.0M | 2026-06-16 | Seoul | Biotech |
| 64 | HMNC Brain Health | Series B | $50.0M | 2026-06-15 | Munich | Biotech |
| 65 | ThunderBio Innovation | Series B | $17.7M | 2026-06-15 | Jiaxing | Biotech |
| 66 | Zumutor Biologics | Series B | $7.3M | 2026-06-13 | Woburn | Biotech |
| 67 | SonoThera | Series B | $125.0M | 2026-06-10 | South San Francisco | Biotech |
| 68 | City Therapeutics | Series B | $99.5M | 2026-06-08 | Cambridge | Biotech |
| 69 | Ona Therapeutics | Series B | $86.6M | 2026-06-04 | Barcelona | Biotech |
| 70 | Contraline | Series B | $92.5M | 2026-06-02 | Charlottesville | Biotech |
| 71 | HemaCell | Series B | $14.8M | 2026-06-02 | Suzhou | Biotech |
| 72 | Elemental Machines | Series B | $5.7M | 2026-05-27 | Cambridge | Artificial intelligence |
| 73 | Phytolon | Series B | $23.6M | 2026-05-26 | Yoqne`am `illit | Biotech |
| 74 | Furong Biotech | Series B | $14.7M | 2026-05-20 | Suzhou | Biotech |
| 75 | Bivision | Series B | $58.8M | 2026-05-18 | Shanghai | Biotech |
| 76 | CREATE Medicines | Series B | $122.0M | 2026-05-14 | Cambridge | Biotech |
| 77 | NVision Quantum Technologies | Series B | $38.0M | 2026-05-13 | Ulm | Biotech |
| 78 | Starna Therapeutics | Series B | $40.0M | 2026-05-11 | Suzhou | Biotech |
| 79 | Ruijiakang | Series B | $1.4M | 2026-05-11 | Wuhan | Biotech |
| 80 | LTZ Therapeutics | Series B | $38.0M | 2026-05-06 | San Francisco | Biotech |
| 81 | Windward Bio | Series B | $165.0M | 2026-05-04 | Basel | Biotech |
| 82 | Allyx Therapeutics | Series B | $26.5M | 2026-05-01 | New Haven | Biotech |
| 83 | Novamab | Series B | $43.9M | 2026-04-24 | Shanghai | Biotech |
| 84 | Hexaell Biotech | Series B | $14.6M | 2026-04-24 | Shanghai | Biotech |
| 85 | Restore Vision | Series B | $8.2M | 2026-04-15 | Tokyo | Biotech |
| 86 | Spiral Therapeutics | Series B | $27.0M | 2026-04-14 | San Francisco | Biotech |
| 87 | Neomorph | Series B | $100.0M | 2026-04-13 | San Diego | Biotech |
| 88 | AnBogen Therapeutics | Series B | $7.3M | 2026-04-13 | Nankang | Biotech |
| 89 | Sidewinder Therapeutics | Series B | $137.0M | 2026-04-08 | San Diego | Biotech |
| 90 | Incyclix Bio | Series B | $5.0M | 2026-04-08 | Durham | Biotech |
| 91 | Ruijiming Biological | Series B | $2.5M | 2026-04-08 | Shandong | Biotech |
| 92 | Kytopen | Series B | $1.6M | 2026-04-07 | Cambridge | Biotech |
| 93 | DynaFlow | Series B | $14.5M | 2026-04-03 | Fengtai | Biotech |
| 94 | Syneron | Series B | $150.0M | 2026-03-31 | Guangzhou | Artificial intelligence |
| 95 | Ambrosia Biosciences | Series B | $100.0M | 2026-03-31 | Boulder | Biotech |
| 96 | Standing Ovation | Series B | $28.6M | 2026-03-31 | Paris | Biotech |
| 97 | Pinnacle Medicines | Series B | $89.0M | 2026-03-26 | Doylestown | Biotech |
| 98 | Yunying Medical | Series B | $14.2M | 2026-03-23 | Shanghai | Biotech |
| 99 | Crossbow Therapeutics | Series B | $77.0M | 2026-03-18 | Cambridge | Biotech |
| 100 | Unnatural Products | Series B | $45.0M | 2026-03-16 | Santa Cruz | Artificial intelligence |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 1,423.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | MGI Tech | Series B | $1.0B | 2020-05-28 | Shenzhen | Biotech |
| 2 | SFCC | Series B | $646.8M | 2022-12-09 | Shenzhen | Biotech |
| 3 | Kailera Therapeutics | Series B | $600.0M | 2025-10-14 | Waltham | Biotech |
| 4 | Laronde | Series B | $440.0M | 2021-08-30 | Cambridge | Biotech |
| 5 | Believer Meats | Series B | $347.0M | 2021-12-17 | Jerusalem | Biotech |
| 6 | Ollin Biosciences | Series B | $330.0M | 2026-06-24 | Austin | Biotech |
| 7 | Cardurion Pharmaceuticals | Series B | $260.0M | 2024-07-16 | Boston | Biotech |
| 8 | Kardigan | Series B | $254.0M | 2025-10-14 | South San Francisco | Biotech |
| 9 | Mirador Therapeutics | Series B | $250.0M | 2026-01-12 | San Diego | Biotech |
| 10 | AltruBio | Series B | $225.0M | 2024-05-21 | Los Altos | Biotech |
| 11 | Orna Therapeutics | Series B | $221.0M | 2022-08-16 | Watertown | Biotech |
| 12 | Incode Technologies | Series B | $220.0M | 2021-12-07 | San Francisco | Biotech |
| 13 | Metsera | Series B | $215.0M | 2024-11-13 | New York | Biotech |
| 14 | Immunai | Series B | $215.0M | 2021-10-27 | New York | Artificial intelligence |
| 15 | Upstream Bio | Series B | $200.0M | 2023-06-08 | Waltham | Biotech |
| 16 | Sironax | Series B | $200.0M | 2022-08-02 | Beijing | Biotech |
| 17 | Aera Therapeutics | Series B | $193.0M | 2023-02-16 | Boston | Biotech |
| 18 | Osanni Bio | Series B | $190.0M | 2026-06-23 | San Francisco | Biotech |
| 19 | Marea Therapeutics | Series B | $190.0M | 2024-06-18 | San Francisco | Biotech |
| 20 | Repertoire Immune Medicines | Series B | $189.0M | 2021-04-13 | Cambridge | Biotech |
| 21 | Tune Therapeutics | Series B | $175.0M | 2025-01-12 | Durham | Biotech |
| 22 | Aktis Oncology | Series B | $175.0M | 2024-09-30 | Boston | Biotech |
| 23 | Capstan Therapeutics | Series B | $175.0M | 2024-03-20 | San Diego | Biotech |
| 24 | Mariana Oncology | Series B | $175.0M | 2023-09-07 | Watertown | Biotech |
| 25 | Asimov | Series B | $175.0M | 2023-01-05 | Boston | Artificial intelligence |
| 26 | Haihe Biopharma | Series B | $171.0M | 2020-07-24 | Shanghai | Biotech |
| 27 | Instil Bio | Series B | $170.2M | 2020-08-03 | Dallas | Biotech |
| 28 | AffaMed Therapeutics | Series B | $170.0M | 2021-03-30 | New City | Biotech |
| 29 | Barinthus Biotherapeutics | Series B | $168.0M | 2021-03-17 | Harwell | Biotech |
| 30 | Windward Bio | Series B | $165.0M | 2026-05-04 | Basel | Biotech |
| 31 | Nuvig Therapeutics | Series B | $161.0M | 2024-12-05 | Redwood City | Biotech |
| 32 | Frontera Therapeutics | Series B | $160.0M | 2022-06-24 | Bedford | Biotech |
| 33 | Genor Biopharma | Series B | $160.0M | 2020-06-01 | Beijing | Biotech |
| 34 | Engrail Therapeutics | Series B | $157.0M | 2024-03-19 | San Diego | Biotech |
| 35 | Quell Therapeutics | Series B | $156.0M | 2021-11-29 | London | Biotech |
| 36 | AIRNA | Series B | $155.0M | 2025-04-01 | Cambridge | Biotech |
| 37 | Strand Therapeutics | Series B | $153.0M | 2025-08-03 | Cambridge | Biotech |
| 38 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 39 | Graphite Bio | Series B | $150.7M | 2021-03-15 | South San Francisco | Biotech |
| 40 | Matchpoint Therapeutics | Series B | $150.0M | 2026-10-07 | Cambridge | Biotech |
| 41 | Syneron | Series B | $150.0M | 2026-03-31 | Guangzhou | Artificial intelligence |
| 42 | Latigo Biotherapeutics | Series B | $150.0M | 2025-03-17 | Thousand Oaks | Biotech |
| 43 | Septerna | Series B | $150.0M | 2023-07-11 | San Francisco | Biotech |
| 44 | Alkeus Pharmaceuticals | Series B | $150.0M | 2023-06-05 | Cambridge | Biotech |
| 45 | MOMA Therapeutics | Series B | $150.0M | 2022-05-10 | Cambridge | Biotech |
| 46 | BostonGene | Series B | $150.0M | 2022-04-06 | Waltham | Biotech |
| 47 | JOINN Biologics | Series B | $150.0M | 2021-08-01 | Richmond | Biotech |
| 48 | WuXi Diagnostics | Series B | $150.0M | 2021-02-23 | Shanghai | Biotech |
| 49 | Visen Pharmaceuticals | Series B | $150.0M | 2021-01-08 | Shanghai | Biotech |
| 50 | Noema Pharma | Series B | $147.2M | 2024-12-11 | Basel | Biotech |
| 51 | Azafaros | Series B | $146.7M | 2025-05-13 | Leiden | Biotech |
| 52 | Zhaoke Ophthalmology Pharmaceutical | Series B | $145.0M | 2020-10-12 | Hong Kong | Biotech |
| 53 | Outpace Bio | Series B | $144.0M | 2024-08-01 | Seattle | Biotech |
| 54 | Abdera Therapeutics | Series B | $142.0M | 2023-04-20 | Vancouver | Biotech |
| 55 | AAVantgarde Bio | Series B | $141.0M | 2025-11-03 | Milan | Biotech |
| 56 | Avistone Pharmaceuticals | Series B | $140.7M | 2023-12-28 | Beijing | Biotech |
| 57 | Harbinger Health | Series B | $140.0M | 2023-09-28 | Cambridge | Artificial intelligence |
| 58 | RVAC Medicines | Series B | $140.0M | 2022-04-26 | Singapore | Biotech |
| 59 | Shoreline Biosciences | Series B | $140.0M | 2021-11-02 | La Jolla | Biotech |
| 60 | Sidewinder Therapeutics | Series B | $137.0M | 2026-04-08 | San Diego | Biotech |
| 61 | VelosBio | Series B | $137.0M | 2020-07-08 | San Diego | Biotech |
| 62 | Soufflé Therapeutics | Series B | $135.0M | 2026-10-13 | Boston | Biotech |
| 63 | Splice Bio | Series B | $135.0M | 2025-06-11 | Barcelona | Biotech |
| 64 | Chroma Medicine | Series B | $135.0M | 2023-02-28 | Cambridge | Biotech |
| 65 | Juno Therapeutics | Series B | $134.0M | 2014-08-05 | Seattle | Biotech |
| 66 | ARTBIO | Series B | $132.0M | 2025-07-29 | Cambridge | Biotech |
| 67 | Alterome Therapeutics | Series B | $132.0M | 2024-04-03 | San Diego | Biotech |
| 68 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 69 | Protego Biopharma | Series B | $130.0M | 2025-12-01 | San Diego | Biotech |
| 70 | GlycoEra | Series B | $130.0M | 2025-05-27 | wädenswil-zurich | Biotech |
| 71 | Halda Therapeutics | Series B | $126.0M | 2024-08-12 | New Haven | Biotech |
| 72 | SonoThera | Series B | $125.0M | 2026-06-10 | South San Francisco | Biotech |
| 73 | Diagonal Therapeutics | Series B | $125.0M | 2026-01-08 | Watertown | Biotech |
| 74 | Santa Ana Bio | Series B | $125.0M | 2024-06-13 | Alameda | Biotech |
| 75 | Design Therapeutics | Series B | $125.0M | 2021-01-27 | Solana Beach | Biotech |
| 76 | CREATE Medicines | Series B | $122.0M | 2026-05-14 | Cambridge | Biotech |
| 77 | Triana Biomedicines | Series B | $120.0M | 2025-12-03 | Lexington | Biotech |
| 78 | FIRE1 | Series B | $120.0M | 2025-01-07 | Dublin | Biotech |
| 79 | Idrx | Series B | $120.0M | 2024-08-07 | Cambridge | Biotech |
| 80 | Pheon Therapeutics | Series B | $120.0M | 2024-05-21 | London | Biotech |
| 81 | OriginCell | Series B | $120.0M | 2022-08-01 | Pudong | Biotech |
| 82 | Remilk | Series B | $120.0M | 2022-01-04 | Tel Aviv | Biotech |
| 83 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
| 84 | Helio Health | Series B | $118.0M | 2021-07-15 | Irvine | Artificial intelligence |
| 85 | Amunix | Series B | $117.0M | 2021-03-04 | South San Francisco | Biotech |
| 86 | Expedition Therapeutics | Series B | $115.0M | 2026-08-05 | San Francisco | Biotech |
| 87 | SalioGen Therapeutics | Series B | $115.0M | 2022-01-05 | Burlington | Biotech |
| 88 | Talaris Therapeutics | Series B | $115.0M | 2020-10-06 | Louisville | Biotech |
| 89 | Semma Therapeutics | Series B | $114.0M | 2017-11-29 | Cambridge | Biotech |
| 90 | ProfoundBio | Series B | $112.0M | 2024-02-13 | Seattle | Biotech |
| 91 | Sanegene Bio | Series B | $110.0M | 2025-12-08 | Woburn | Biotech |
| 92 | Curevo | Series B | $110.0M | 2025-03-17 | Bothell | Biotech |
| 93 | T-knife | Series B | $110.0M | 2021-08-02 | Berlin | Biotech |
| 94 | Alltrna | Series B | $109.0M | 2023-08-09 | Cambridge | Biotech |
| 95 | D3 Bio | Series B | $108.0M | 2025-12-09 | Wuxi Shi | Biotech |
| 96 | EpiBiologics | Series B | $107.0M | 2026-01-08 | San Mateo | Biotech |
| 97 | Profluent Bio | Series B | $106.0M | 2025-11-19 | Emeryville | Artificial intelligence |
| 98 | Pathalys Pharma | Series B | $105.0M | 2024-08-20 | Raleigh | Biotech |
| 99 | Variant Bio | Series B | $105.0M | 2021-11-09 | Seattle | Biotech |
| 100 | Akouos | Series B | $105.0M | 2020-03-03 | Boston | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 1,423.
By month
| Month | Companies |
|---|---|
| 2024-11 | 8 |
| 2024-12 | 10 |
| 2025-01 | 11 |
| 2025-02 | 9 |
| 2025-03 | 10 |
| 2025-04 | 14 |
| 2025-05 | 11 |
| 2025-06 | 5 |
| 2025-07 | 11 |
| 2025-08 | 12 |
| 2025-09 | 21 |
| 2025-10 | 17 |
| 2025-11 | 12 |
| 2025-12 | 20 |
| 2026-01 | 24 |
| 2026-02 | 12 |
| 2026-03 | 10 |
| 2026-04 | 11 |
| 2026-05 | 11 |
| 2026-06 | 18 |
| 2026-07 | 10 |
| 2026-08 | 15 |
| 2026-09 | 19 |
| 2026-10 | 9 |
Table 3. Biotech startups that raised Series B by month of the round. Source: FundingWatcher. Data as of 23 October 2026. Base: 1,423.
Country
| Country | Companies |
|---|---|
| United States | 685 |
| China | 297 |
| South Korea | 78 |
| United Kingdom | 71 |
| France | 38 |
| Germany | 35 |
| Switzerland | 31 |
| Israel | 26 |
| Japan | 23 |
| Canada | 18 |
| The Netherlands | 14 |
| Belgium | 13 |
| Spain | 10 |
| Singapore | 10 |
| Ireland | 10 |
Table 4. Biotech startups that raised Series B by country. Source: FundingWatcher. Data as of 23 October 2026. Base: 1,423.
City
| City | Companies |
|---|---|
| Cambridge | 68 |
| San Diego | 53 |
| Shanghai | 52 |
| Boston | 40 |
| San Francisco | 34 |
| Beijing | 31 |
| Suzhou | 28 |
| Seoul | 26 |
| New York | 26 |
| London | 23 |
| Hangzhou | 23 |
| Seattle | 23 |
| Shenzhen | 18 |
| South San Francisco | 15 |
| Paris | 14 |
Table 5. Biotech startups that raised Series B by city. Source: FundingWatcher. Data as of 23 October 2026. Base: 1,423.
Sector
| Sector | Companies |
|---|---|
| Biotech | 1,423 |
| Health care | 1,232 |
| Software | 141 |
| Artificial intelligence | 78 |
| Hardware | 47 |
| Cybersecurity | 11 |
| Fintech | 10 |
| Energy | 8 |
| Commerce | 5 |
| Education | 5 |
Table 6. Biotech startups that raised Series B by sector. Source: FundingWatcher. Data as of 23 October 2026. Base: 1,423.
Biotech at other stages
Other sectors that raised Series B
software startups that raised Series B5,740
health care startups that raised Series B2,750
AI startups that raised Series B1,636
fintech startups that raised Series B1,501
commerce startups that raised Series B1,538
hardware startups that raised Series B2,357
education startups that raised Series B488
cybersecurity startups that raised Series B643
energy startups that raised Series B512
Cite: FundingWatcher, 1,423 biotech companies whose most recent round is Series B, 23 October 2026. https://fundingwatcher.com/startups/biotech/series-b/